Overview

A 21 Day Pharmacokinetics Study in Papulopustular Rosacea

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the pharmacokinetics of once daily topical gel and confirm that steady state conditions are reached under maximal use conditions following 3 weeks of daily applications.
Phase:
Phase 1
Details
Lead Sponsor:
Cutanea Life Sciences, Inc.
Maruho Co., Ltd.